Gemigliptin is a medication used to treat type 2 diabetes. However, during the manufacturing process of Gemigliptin, impurities may be formed that can affect the safety and efficacy of the final product. These impurities must be identified and controlled to ensure the purity and quality of the medication. Various analytical techniques are used to detect and quantify these impurities, and strict regulatory guidelines must be followed to ensure patient safety.